Bank of Nova Scotia Trust’s Eli Lilly LLY Stock Holding History

Bank of Nova Scotia Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$380K	Sell	413 -34	-8%	-$34.5K	0.03%	122
2025 Q4	$480K	Hold	447	–	–	0.04%	112
2025 Q3	$341K	Hold	447	–	–	0.03%	111
2025 Q2	$348K	Sell	447 -45	-9%	-$35K	0.03%	109
2025 Q1	$406K	Buy	+492	New	+$409K	0.04%	107
2024 Q4	–	Sell	-542	Closed	-$480K	–	136
2024 Q3	$480K	Buy	542 +192	+55%	+$173K	0.05%	105
2024 Q2	$317K	Sell	350 -100	-22%	-$80K	0.04%	110
2024 Q1	$350K	Hold	450	–	–	0.04%	111
2023 Q4	$262K	Sell	450 -41	-8%	-$23.9K	0.03%	117
2023 Q3	$264K	Buy	491 +16	+3%	+$8.24K	0.03%	117
2023 Q2	$223K	Buy	+475	New	+$199K	0.02%	129
2017 Q4	–	Sell	-2,400	Closed	-$205K	–	277
2017 Q3	$205K	Buy	+2,400	New	+$197K	0.02%	133

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of Nova Scotia Trust's LLY Position: Q1 2026 in Review

Bank of Nova Scotia Trust reduced its Eli Lilly (LLY) stake by 7.6% in Q1 2026, selling an estimated $34.5K and leaving 413 shares worth $380K. The position accounts for 0.03% of the portfolio, ranked #122.

Bank of Nova Scotia Trust first reported a position in LLY in Q3 2017 and has held it in 12 quarters since. The position peaked at $480K in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Bank of Nova Scotia Trust held 413 shares of Eli Lilly worth $380K as of Q1 2026.
Bank of Nova Scotia Trust sold 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
Eli Lilly made up 0.03% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #122 holding.
Bank of Nova Scotia Trust first reported a position in Eli Lilly in Q3 2017 and has held it in 12 quarters since.
Bank of Nova Scotia Trust's Eli Lilly position peaked at $480K in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.